[1]温广华.18F-FDG PET显像在肝癌中的应用[J].国际放射医学核医学杂志,2003,27(1):21-24.
　WEN Guang-hua.The applications of 18F-FDG PET in liver carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(1):21-24.
点击复制

18F-FDG PET显像在肝癌中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第1期
页码:
21-24
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The applications of 18F-FDG PET in liver carcinoma
作者:
温广华
610041 成都, 四川大学华西医院核医学科
Author(s):
WEN Guang-hua
Department of Nuclear Medicine, West China Hospital of Sichuan University, Sichuan Chendu 610041, China
关键词:
肝癌; 正电子发射体层显像; 18F-氟代脱氧葡萄糖
Keywords:
liver carcinoma; positron emission tomogrphy; fluorine-18-deoxyglucosein
分类号:
R817.4
摘要:
18F-FDG PET在肝脏的原发肿瘤和转移性肿瘤的诊断中有重要价值,特别是在肝肿瘤的诊断、分期和治疗方案的选择方面。结合CT、MRI和超声可以提高诊断的准确性,同时,在对肝肿瘤疗效监测以及评价手术效果方面也有重要作用。
Abstract:
PET scanning in liver carcinoma has a definite clinical impact on identification of primary and metastatic tumor-especially on diagnosis, staging, and therapy of liver carcinoma. In addition, combined with CT, MRI, and ultrasound, PET can improve curative effect. Meanwhile, it is also important to curative effect of liver carcinoma.

参考文献/References:

[1] Khan MA,Combs CS,Brunt EM,et al. Positron emission tommography scanning in the evaluation of hepatocellular carcinoma[J]. J Hepatol, 2000, 32(5):792-797.
[2] Hustinx R, Paulus P, Jacquet N, et al. Clinical evaluation of whole-body 18F-flouro-deoxyglucose positron emission tomography in the detection of liver metastases[J]. Ann Oncol, 1998,9(4):397-401.
[3] Iwata Y, Shiomi S, Sasaki N, et al. Clinical usefulness of positron emission tomography with flourine-18-fluo-rodeoxyglucose in the diagnosis of liver tumors[J]. Ann Nucl Med, 2000, 14(2):121-126.
[4] Frohlich A, Diederichs CS, Staib L, et al. Detction of liver metastases from pancreatic cancer using FDG PET[J]. J Nucl Med, 1999,40(2):250-255.
[5] Nakamoto Y, Higashi T, Sakahara H, et al. Contribution of PET in the detection of liver metastases from pancreatic tu-mors[J]. Clin Radiol, 1999, 54(4):248-252.
[6] Huebner RH, Park KC, Shepherd JK, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorrectal cancer[J]. J Nucl Med, 2000, 41(7):1177-1189.
[7] Imdahl A, Reinhardt MJ, Nitzsche EU, et al. Impact of 18F-FDG PET for detection making in colorrectal cancer recur-rence[J]. Langenbecks Arch Surg, 2000, 385(2):129-134.
[8] Hung GU, Shiau YC, Tsai SC, et al. Value of 18F-FDGPET in the evaluation of recurrent colorectal cancer[J]. Anticancer Res, 2001, 21:(2B):1375-1378.
[9] Zhuang H, Sinha P, Pourdehnad M, et al. The role of positron emission tomogrphy with fluorine-18-deoxygluco-sein identifying colorectal cancer metastases to liver[J].Nucl Med Commun, 2000, 21(9):793-798.
[10] Lai DT, Fulham M, Stephen MS, et al. The role of whole-body positron emission tomography with [18F]fluorodeoxyglu-cose in identfying operabie colorectal cancer metastases to the liver[J]. Arch Surg, 1996, 131(7):703-707.
[11] Esik O, Szavcsur P, Szakall SJr, et al. Angiography effec-tively supports the diagnosis of hepatic metastsese in medullary thyroid carcinoma[J]. Cancer, 2001, 91(11):2084-2095.
[12] Bangerter M, Moog F, Griesshammer M, et al. Usefulness ofFDG PET in diagnosing primary lymphoma of the liver[J]. Int J Hematol, 1997, 66(4):517-520.
[13] Daw NC, Kaste SC, Hill DA, et al. Metastatic osteosarcoma to liver after treatment for synovial sarcoma:acase report[J].Pediatr Hematol Oncol, 2001, 18(2):123-128.
[14] Kurtaran A, Becherer A, Pfeffel F, et al. 18F-FDG PET features of focal nodular hyperplasia(FNH)of the liver[J]. Liver, 2000, 20(6):487-490.
[15] Vitola JV, Delbeke D, Meranze SG, et al. Positron emission tomography with 18F-FDG evaluate the results of hepatic chemoebolization[J].Cancer, 1996, 78(10):2216-2222.
[16] Topal B, Flamen P, Aerts R, et al. Clinical value of whole-body emission tomography in potentially curable liver metastases[J]. Eur J Surg Oncol, 2001, 27(2):175-179.
[17] Zhao S, Moore JV, Waller ML, et al. Positron emission to-mography of murine liver metastses and the effects of treatment by comrbetastatin A-4[J]. Eur J Nucl Med, 1999, 26(3):231-238.[18] Kissel J, Port RE, Zaers J, et al. Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach[J]. Med Phys, 1999, 26(4):609-615.
[19] Bender H, Bangard N, Metten N, et al. Possible role of FDG PET the early predecation of therapy outcome in liver metastases of colorectal cancer[J]. Hybridoma, 1999, 18(1):87-91.
[20] Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG PET before hepatic resection for metastatic colorectal:a prospective database study[J]. Ann Surg,2001,233(3):293-299.
[21] Schroder O, Trojan J, Zeuzem S, et al. Limiited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis virus infection[J]. Nuklearmedizin, 1998, 8:279-285.
[22] Crippa F, Gavazzi C, Bozzetti F, et al. The influence of blood glucose levels on [18F-FDG uptake in cander:A PET study in liver metastases from colorectal carcinomas[J].Tu-mor, 1997, 83(4):748-752.

相似文献/References:

[1]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):1.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):10.
[3]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):148.
[4]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):197.
[5]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):201.
[6]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):205.
[7]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):209.
[8]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):213.
[9]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):216.
[10]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
　LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):220.

备注/Memo

备注/Memo:
收稿日期:2002-06-25。
作者简介:温广华(1978-),男,硕士研究生,主要从事肿瘤核医学的研究。
更新日期/Last Update: 1900-01-01